ArticleProceedings of the National Academy of Sciences of the United States of America2015

EGFR inhibition evokes innate drug resistance in lung cancer cells by preventing Akt activity and thus inactivating Ets-1 function.

Janyaporn Phuchareon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.